These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 2576255

  • 1. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G.
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [Abstract] [Full Text] [Related]

  • 2. A clinical overview of a new triphasic contraceptive containing gestodene.
    Christie T.
    Int J Fertil; 1989 Sep; 34 Suppl():40-9. PubMed ID: 2576257
    [Abstract] [Full Text] [Related]

  • 3. A multicenter clinical evaluation of a new monophasic combination: Minulet (gestodene and ethinyl estradiol).
    de Andrade RP.
    Int J Fertil; 1989 Sep; 34 Suppl():22-30. PubMed ID: 2576253
    [Abstract] [Full Text] [Related]

  • 4. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Sep; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 5. Clinical and metabolic effects of gestodene and levonorgestrel.
    Rabe T, Runnebaum B, Kohlmeier M, Harenberg J, Weicker H.
    Int J Fertil; 1987 Sep; 32 Suppl():29-44. PubMed ID: 2906345
    [Abstract] [Full Text] [Related]

  • 6. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
    Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.
    Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778
    [Abstract] [Full Text] [Related]

  • 7. Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 microg/ ethinylestradiol 15 microg and a 21-day regimen of desogestrel 150 microg/ethinylestradiol 20 microg.
    Eur J Contracept Reprod Health Care; 1999 Nov; 4 Suppl 2():17-25. PubMed ID: 14677621
    [Abstract] [Full Text] [Related]

  • 8. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S.
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [Abstract] [Full Text] [Related]

  • 9. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
    Shoupe D.
    Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925
    [Abstract] [Full Text] [Related]

  • 10. Effect of two monophasic oral contraceptives containing gestodene or desogestrel on serum lipoprotein lipid levels.
    Leuven JA, de Pagter HA, Dersjant-Roorda MA, Helmerhorst FA, Roelofsen J.
    Int J Fertil; 1989 Sep; 34 Suppl():55-60. PubMed ID: 2576261
    [Abstract] [Full Text] [Related]

  • 11. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J.
    Int J Fertil; 1991 Sep; 36 Suppl 1():25-31. PubMed ID: 1678378
    [Abstract] [Full Text] [Related]

  • 12. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
    Dieben TO, van Beek A, Coelingh Bennink HJ.
    Arzneimittelforschung; 1991 Sep; 41(9):996-8. PubMed ID: 1839126
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
    Bilotta P, Favilli S.
    Arzneimittelforschung; 1988 Jul; 38(7):932-4. PubMed ID: 2974702
    [Abstract] [Full Text] [Related]

  • 14. Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel.
    Endrikat J, Cronin M, Gerlinger C, Ruebig A, Schmidt W, Düsterberg B.
    Contraception; 2001 Sep; 64(3):201-7. PubMed ID: 11704101
    [Abstract] [Full Text] [Related]

  • 15. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ, Pedersen JH, Fioretti P, Roberts HE.
    Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
    [Abstract] [Full Text] [Related]

  • 16. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H.
    Acta Obstet Gynecol Scand; 1988 Jan; 67(2):171-4. PubMed ID: 2972160
    [Abstract] [Full Text] [Related]

  • 17. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
    Mango D, Ricci S, Manna P, Miggiano GA, Serra GB.
    Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
    [Abstract] [Full Text] [Related]

  • 18. Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol. Latin American Oral Contraceptive Study Group.
    Contraception; 1994 Sep; 50(3):201-14. PubMed ID: 7805371
    [Abstract] [Full Text] [Related]

  • 19. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
    Dieben TO, op ten Berg MT, Coelingh Bennink HJ.
    Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527
    [Abstract] [Full Text] [Related]

  • 20. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
    Anttila L, Kunz M, Marr J.
    Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.